Properties of a T-type Ca2+channel-activated slow afterhyperpolarization in thalamic paraventricular nucleus and other thalamic midline neurons

J Neurophysiol. 2009 Jun;101(6):2741-50. doi: 10.1152/jn.91183.2008. Epub 2009 Mar 25.

Abstract

Burst firing mediated by a low-threshold spike (LTS) is the hallmark of many thalamic neurons. However, postburst afterhyperpolarizations (AHPs) are relatively uncommon in thalamus. We now report data from patch-clamp recordings in rat brain slice preparations that reveal an LTS-induced slow AHP (sAHP) in thalamic paraventricular (PVT) and other midline neurons, but not in ventrobasal or reticular thalamic neurons. The LTS-induced sAHP lasts 8.9 +/- 0.4 s and has a novel pharmacology, with resistance to tetrodotoxin and cadmium and reduction by Ni(2+) or nominally zero extracellular calcium concentration, which also attenuate both the LTS and sAHP. The sAHP is inhibited by 10 mM intracellular EGTA or by equimolar replacement of extracellular Ca(2+) with Sr(2+), consistent with select activation of LVA T-type Ca(2+) channels and subsequent Ca(2+) influx. In control media, the sAHP reverses near E(K(+)), shifting to -78 mV in 10.1 mM [K(+)](o) and is reduced by Ba(2+) or tetraethylammonium. Although these data are consistent with opening of Ca(2+)-activated K(+) channels, this sAHP lacks sensitivity to specific Ca(2+)-activated K(+) channel blockers apamin, iberiotoxin, charybdotoxin, and UCL-2077. The LTS-induced sAHP is suppressed by a beta-adrenoceptor agonist isoproterenol, a serotonin 5-HT(7) receptor agonist 5-CT, a neuropeptide orexin-A, and by stimulation of the cAMP/protein kinase A pathway with 8-Br-cAMP and forskolin. The data suggest that PVT and certain midline thalamic neurons possess an LTS-induced sAHP that is pharmacologically distinct and may be important for information transfer in thalamic-limbic circuitry during states of attentiveness and motivation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adrenergic beta-Agonists / pharmacology
  • Animals
  • Animals, Newborn
  • Barium / pharmacology
  • Cadmium / pharmacology
  • Calcium / metabolism
  • Calcium / pharmacology
  • Calcium Channels, T-Type / physiology*
  • Chelating Agents / pharmacology
  • Cyclic AMP / metabolism
  • Egtazic Acid / pharmacology
  • Electric Stimulation / methods
  • In Vitro Techniques
  • Isoproterenol / pharmacology
  • Membrane Potentials / drug effects
  • Membrane Potentials / physiology
  • Midline Thalamic Nuclei / cytology*
  • Neural Pathways / physiology
  • Neurons / cytology
  • Neurons / drug effects
  • Neurons / physiology*
  • Patch-Clamp Techniques
  • Potassium / pharmacology
  • Potassium Channel Blockers / pharmacology
  • Rats
  • Rats, Wistar
  • Signal Transduction / drug effects
  • Sodium Channel Blockers / pharmacology
  • Strontium / pharmacology
  • Tetrodotoxin / pharmacology

Substances

  • Adrenergic beta-Agonists
  • Calcium Channels, T-Type
  • Chelating Agents
  • Potassium Channel Blockers
  • Sodium Channel Blockers
  • Cadmium
  • Barium
  • Tetrodotoxin
  • Egtazic Acid
  • Cyclic AMP
  • Isoproterenol
  • Potassium
  • Calcium
  • Strontium